GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
St. Jude Medical, Inc. (STJ) [hlAlert]

Rating:
Outperform
STJ
up 64.20 %

St. Jude Medical, Inc. (STJ) upgraded to Outperform by Wedbush

Posted on: Friday,  May 31, 2013  8:25 AM ET by Wedbush

Wedbush rated Outperform St. Jude Medical, Inc. (NYSE: STJ) on 05/31/2013, when the stock price was $44.11.
Since then, St. Jude Medical, Inc. has gained 64.20% as of 01/28/2016's recent price of $72.43.
If you would have followed this Wedbush 's recommendation on STJ, you would have gained 64.2% of your investment in 972 days.

St. Jude Medical, Inc. (St. Jude)develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiology and cardiac surgery and atrial fibrillation therapy areas and implantable neurostimulation devices for the management of chronic pain. The Company operates in four business segments: Cardiac Rhythm Management (CRM), Cardiovascular (CV), Atrial Fibrillation (AF) and Neuromodulation Systems (Neuro). On July 3, 2008, the Company completed the acquisition of EP MedSystems, Inc. On December 19, 2008, St. Jude acquired Radi Medical Systems. On December 22, 2008, St. Jude acquired MediGuide Inc.

Wedbush is Headquartered in Los Angeles, California with over 90 offices and more than 125 correspondent offices, our commitment to providing relentless, customized service is the foundation of our consistent growth. We deliver superior investment ideas and products through exceptional customer care, financial security, continuity and advanced technology.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/31/2013 8:25 AM Buy
None
44.11
as of 12/13/2013
1 Week down  -2.94 %
1 Month up  0.57 %
3 Months up  9.78 %
1 YTD up  31.46 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/21/2011 9:25 AM Hold
None
53.19 46.00
10/21/2010 9:25 AM Hold
None
38.63 38.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy